65438+September 0986-65438+July 0989: Postgraduate of Basic Medicine, Henan Medical University, engaged in cellular immunity research of animals infected with Leishmania donovani.
65438+August 0989-65438+March 0990: Henan Institute of Medical Sciences participated in the development of hepatitis D immune diagnosis kit.
1April 1990-1August 1990: Da Rui Biological Products Co., Ltd. participated in the research and development of biological products. In my study and work, I have a strong interest in the pathogenesis, biology and targeted therapy of tumors.
1September 1990-1June 1993: Ph.D. candidate of pharmaceutical biotechnology Institute of China Academy of Medical Sciences (Union Medical College), seriously ill. He studied under Professor Zhen (Professor, Academician of China Academy of Engineering) and was a doctoral student in microbial pharmacology. I have been engaged in the research work of monoclonal antibody-oriented tumor treatment, including the isolation and fermentation of actinomycetes (micromonospora), the detection, separation and identification of anti-tumor active substances, the detection of anti-microbial and anti-tumor activities in vitro and in vivo, and the observation of toxic and side effects, and obtained a new species of micromonospora that produced high-efficiency anti-tumor active substances. Because of its high activity, low yield and high instability, the purity of active substances is difficult to meet the requirements of molecular identification, so it was not identified until some time ago, which may be a new high-activity anti-tumor antibiotic.
65438+1July, 1993 to present: Teaching in the School of Life Sciences of Capital Normal University, engaged in teaching and scientific research of human anatomy, physiology and reproductive health. At present, the main research direction is the reproductive regulation of traditional Chinese medicine, and the regulation of traditional Chinese medicine on immune and anti-tumor cell growth is also studied.